W hat do your circadian rhythm, pupillary response, mood, and sleep have in common with the spots on a frog? The answer is melanopsin. Almost 100 years ago, it was observed that totally blind patients with intact globes and no detectable rod or cone function were able to maintain certain pupillary responses, circadian rhythms, and sleep patterns. In contrast, similar totally blind patients who were bilaterally enucleated had loss of these pupillary reflexes and loss of their circadian rhythm and sleep patterns. Because rods and cones were the only known photosensitive cells in the eye at that time, it was theorized that totally blind individuals with pupillary responses and normal circadian rhythms had some undetectable residual rod or cone function.
Fast forward decades. With advancements in molecular genetics, knockout mice with absolutely no rod or cone function were found to maintain their circadian rhythms, sleep cycle, and some pupillary responses unless they were bilaterally enucleated. This was clear evidence against the residual rod or cone function theory.
Approximately 20 years ago, Iggy Provencio became curious about how the African clawed frog (Xenopus laevis) changed its pigmentation in response to ambient light. He characterized an opsin from a cDNA library derived from the melanophores of the skin of the frog and named it melanopsin, after the melanophores. Melanopsin was found to have a structure similar to all known opsins and, like the four major photopigments in human outer retinas, was found to be a G protein transducing protein that contains the chromophore 11-cis-retinal. Despite being found initially in a vertebrate, melanopsin's protein sequence is much more homologous to invertebrate opsins, a point of evolutionary significance.
Looking beyond the frog, he then had a prince of an idea: perhaps this photopigment was also contained in the eyes of vertebrates. Using a messenger RNA probe, he found that melanopsin was indeed found in vertebrates, including human retinas. Breaking from 150 years of orthodoxy, Provencio found that melanopsin was contained in a previously unidentified photoreceptor that was located within the inner retina. Prior to this finding, photopigments were believed to be only located in the outer segments of the rods and cones. This newly identified photoreceptor was found to be a special set of ganglion cells, now referred to as intrinsically photosensitive retinal ganglion cells (ipRGCs). These ganglion cells are light-sensitive working ganglion cells that also receive input from the retina's rods and cones.
The ipRGCs use a unique photopigment (melanopsin) and differ from rod and cones in other interesting and important ways. IpRGCs are considerably less sensitive to light and generate a much more tonic response than other photoreceptors. This makes them more able to average ambient light over long periods of time. Their spectral sensitivity is maximal in the blue range (480 nm). The melanopsin-triggered G protein cascade used by ipRGCs to transduce light energy into a signal the brain can interpret is different than that found in human rods and cones. The transducing mechanism in ipRGCs uses the cascade employed by invertebrates, another interesting evolutionary preservation. During development, ipRGC's become functional before rods and cones, accounting for the pupillary reflexes of extremely premature infants.
Less than 5% of our ganglion cells are ipRGCs. IpRGCs differ from other ganglion cells because their projections are to non-vision-forming areas including the hypothalamic suprachiasmatic nucleus, the primary site of our circadian clock. Fibers are also sent to the area where photic suppression of melatonin release occurs. These projections, as well as those to other sites in and around the hypothalamus, have control over our sleep patterns. There are also projections to preoptic areas that control anterior pituitary hormonal secretion. Axons are also sent to the olivary pretectal nucleus, an area responsible for light-evoked constriction of the pupil. Other brainstem projections affect mood.
There is emerging clinical evidence that dysfunction of the melanopsin system can result in sleep disorders, seasonal affective disorder, and depression. Because the melanopsin system contributes to the pupillary light reflex, research is being done to establish a measurement of pupillary responses that would test the melanopsin system. Perhaps our standard notation PERRLA will become PERRLAND (Pupils Equal, Round, React to Light and Accommodation and Not Depressed). Even in those of us with a normal melanopsin system, there is some evidence that increasing blue light levels enhances our mood. Many blue lights for this purpose are already commercially available to add blue to your blues.
